(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors
- DOI
- 10.1016/j.pnpbp.2011.02.019
- Published
- 2011-04
- Container
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.pnpbp.2011.02.019,
title = {(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors},
author = {Michael Maes and Brian Leonard and Alberto Fernandez and Marta Kubera and Gabriel Nowak and Rob Veerhuis and Ann Gardner and Piaynuj Ruckoanich and Michel Geffard and Carlo Altamura and Piotr Galecki and Michael Berk},
year = {2011},
journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
doi = {10.1016/j.pnpbp.2011.02.019},
url = {https://doi.org/10.1016/j.pnpbp.2011.02.019}
}RIS
TY - JOUR TI - (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors AU - Michael Maes AU - Brian Leonard AU - Alberto Fernandez AU - Marta Kubera AU - Gabriel Nowak AU - Rob Veerhuis AU - Ann Gardner AU - Piaynuj Ruckoanich AU - Michel Geffard AU - Carlo Altamura AU - Piotr Galecki AU - Michael Berk PY - 2011 JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry DO - 10.1016/j.pnpbp.2011.02.019 UR - https://doi.org/10.1016/j.pnpbp.2011.02.019 ER -
APA
Maes, M., Leonard, B., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C., Galecki, P., & Berk, M. (2011). (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/j.pnpbp.2011.02.019
Source records
- crossref · retrieved 2026-09-26T20:03:21.512Z